Wegovy vs Mounjaro Ireland, best weight loss injection Ireland, Saxenda vs Wegovy, Mounjaro Ireland price
Patients are confused about which GLP-1 medication is approved for what, especially since Ozempic is diabetes-only in Ireland while Wegovy is weight-loss approved despite containing the same active ingredient . This comparison content answers a direct comparison question that users type into Google. The featured snippet opportunity is significant here.
Irish patients who have decided to pursue medical weight loss but do not know which medication to ask their doctor about.
Compare based on efficacy, cost, dosing frequency, and availability in Ireland. Be transparent about what is and is not reimbursed.
Ozempic contains semaglutide but is licensed for type 2 diabetes only, not for weight management, in Ireland. Prescribing it off-label for weight loss is outside the licensed indication and regulatory scrutiny has tightened now that approved weight-loss alternatives exist .
Wegovy contains the same active ingredient as Ozempic, semaglutide, but at a higher dose and with a specific weight management licence. It is indicated for adults with a BMI of thirty or above, or BMI of twenty-seven or above with at least one weight-related comorbidity. It is available on private prescription only with no State reimbursement as of 2026 .
Saxenda contains liraglutide and is currently the only weight-loss drug eligible for reimbursement through Medical Card schemes or Drugs Payment Scheme in Ireland, but only for patients meeting strict HSE criteria .
Mounjaro contains tirzepatide and is a dual GIP and GLP-1 receptor agonist, the first of its kind. Clinical trials showed average weight loss of up to twenty-two point five percent of body weight over seventy-two weeks at the highest dose, making it the most effective injectable weight-loss treatment currently available. It is approved for weight management in Ireland but not reimbursed .
Based on clinical trial data, average weight loss results are approximately five to ten percent for Saxenda, ten to fifteen percent for Wegovy, and fifteen to twenty-two percent for Mounjaro .
Internal Links: Wegovy product page, Mounjaro product page, Saxenda product page
Call to Action: Not sure which medication is right for you? Start our confidential online consultation and let our doctors guide your decision.